At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BIB ProShares Ultra Nasdaq Biotechnology
Market Closed 08-28 16:00:00 EDT
116.39
-6.76
-5.49%
盘后116.31
-0.08-0.07%
19:30 EDT
High122.92Low116.02Vol13.00K
Open122.92D1 Closing123.15Amplitude5.60%
Mkt Cap101.26MTradable Cap101.26MTotal Shares870.00K
T/O1.53MT/O Rate1.49%Tradable Shares870.00K
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run
Simply Wall St.  ·  08-30 07:30
Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run
Crinetics Shareholders Approve Vertex Acquisition at Special Meeting
TIPRANKS  ·  08-29 05:33
Crinetics Shareholders Approve Vertex Acquisition at Special Meeting
Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors
Dow Jones  ·  08-29 04:35
Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors
Amgen Inc. Stock Underperforms Friday When Compared to Competitors
Dow Jones  ·  08-29 04:34
Amgen Inc. Stock Underperforms Friday When Compared to Competitors
Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo
TIPRANKS  ·  08-29 01:20
Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo
Vertex Tests VX-407’s Impact on Birth Control: What It Means for VRTX Investors
TIPRANKS  ·  08-29 00:30
Vertex Tests VX-407’s Impact on Birth Control: What It Means for VRTX Investors
Amgen’s Pediatric Psoriasis Study Wrap-Up: What Apremilast Safety Data Means for Investors
TIPRANKS  ·  08-29 00:30
Amgen’s Pediatric Psoriasis Study Wrap-Up: What Apremilast Safety Data Means for Investors
Political and General News Events from August 28
Reuters  ·  08-28 20:30
Political and General News Events from August 28
Gilead Breaks Ground on Foster City Biologics Facility in $32 Billion US Investment Push
Reuters  ·  08-28 10:17
Gilead Breaks Ground on Foster City Biologics Facility in $32 Billion US Investment Push
Gilead Sciences Director Anthony Welters Disposes of USD 2.64 Million in Common Shares
Reuters  ·  08-28 06:45
Gilead Sciences Director Anthony Welters Disposes of USD 2.64 Million in Common Shares
Gilead’s Bixlenvo approved by FDA for virologically suppressed adults with HIV
TIPRANKS  ·  08-28 05:55
Gilead’s Bixlenvo approved by FDA for virologically suppressed adults with HIV
US FDA Approves Gilead's Once-Daily Combination Pill for HIV Treatment
Reuters  ·  08-28 05:50
US FDA Approves Gilead's Once-Daily Combination Pill for HIV Treatment
U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults with Hiv, Including Those on Complex Regimens
THOMSON REUTERS  ·  08-28 05:47
U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults with Hiv, Including Those on Complex Regimens
Moderna Inc. Stock Slips 4.6%, Underperforms Peers
Dow Jones  ·  08-28 04:34
Moderna Inc. Stock Slips 4.6%, Underperforms Peers
Amgen’s AMG 691 Phase 1 Trial Targets Key Growth in Asian Markets
TIPRANKS  ·  08-28
Amgen’s AMG 691 Phase 1 Trial Targets Key Growth in Asian Markets
Analysts Offer Insights on Healthcare Companies: Verrica Pharmaceuticals (VRCA) and Amgen (AMGN)
TIPRANKS  ·  08-27
Analysts Offer Insights on Healthcare Companies: Verrica Pharmaceuticals (VRCA) and Amgen (AMGN)
HBM Holdings FY26 H1 Profit Falls 11.16% to US$ 64.85 Million; Revenue Rises 20.9% to US$ 122.49 Million
Reuters  ·  08-27
HBM Holdings FY26 H1 Profit Falls 11.16% to US$ 64.85 Million; Revenue Rises 20.9% to US$ 122.49 Million
Amgen, AstraZeneca announce Crossing trial showed ‘meaningful’ improvements
TIPRANKS  ·  08-27
Amgen, AstraZeneca announce Crossing trial showed ‘meaningful’ improvements
Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints
TIPRANKS  ·  08-27
Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints
AstraZeneca, Amgen Phase 3 Trial Shows Tezspire Eases Swallowing Difficulties for EoE Patients
MT Newswires Live  ·  08-27
AstraZeneca, Amgen Phase 3 Trial Shows Tezspire Eases Swallowing Difficulties for EoE Patients
No data available

Introduction

Company Name.
ProShares Ultra Nasdaq Biotechnology
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
Issue price:
--